BARBARA MATOS: Open Payments
NPI 1326766197 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,941 in 82 payments from 15 companies in 2025. Trend: 2023 $14 · 2024 $592 · 2025 $1,941
Food & beverage: $1,857Education: $84
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 22 | $473 |
| ABBVIE INC. | 10 | $289 |
| Madrigal Pharmaceuticals | 11 | $259 |
| Phathom Pharmaceuticals, Inc. | 9 | $161 |
| Janssen Biotech, Inc. | 4 | $141 |
| Ardelyx, Inc. | 8 | $138 |
| GENZYME CORPORATION | 3 | $95 |
| Braintree Laboratories, Inc. | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Celltrion USA Inc. | 2 | $52 |
Products named: Sucraid, REZDIFFRA, DUPIXENT, VOQUEZNA, TREMFYA, IBSRELA, CREON, RINVOQ.
Industry payments across FL — which companies pay providers there.
